Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Percutaneous Inferior Cervical Sympathetic Block for Treatment of Refractory Ventricular Tachycardia

NCT04770051 is registered in ClinicalTrials.gov with University of Missouri-Columbia as lead sponsor.

NCT NCT04770051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04770051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Percutaneous Inferior Cervical Sympathetic Block for Treatment of Refractory Ventricular Tachycardia
Lead sponsor
University of Missouri-Columbia
Phase
Phase 1
Overall status
Withdrawn
Start date
July 1, 2022
Completion date
July 1, 2022
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ventricular tachycardia